Barclays raised the firm’s price target on Thermo Fisher (TMO) to $620 from $610 and keeps an Equal Weight rating on the shares. The company’s “strong” Q4 and building momentum with a “seemingly conservative” core guidance are a positive sentiment shift, making Thermo a favored large cap tools name among investors, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher Scientific Reports Robust 2024 Financials
- Thermo Fisher Scientific Reported Earnings. Did it Beat Estimates?
- Thermo Fisher price target raised to $670 from $630 at Goldman Sachs
- Early notable gainers among liquid option names on January 30th
- Morning Movers: UPS and Cigna plunge double digits following Q4 results